The impact of prophylaxis of healthcare workers on influenza pandemic burden

Journal of the Royal Society Interface

Volumn 4, Issue 15, 2007, Pages 727-734

  Gardam, Michael ^a   Liang, Dong ^b   Moghadas, Seyed M ^c,d   Wu, Jianhong ^b   Zeng, Qingling ^b   Zhu, Huaiping ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b YORK UNIVERSITY   (Canada)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d UNIVERSITY OF WINNIPEG   (Canada)

Author keywords

Antivirals; Epidemic models; Influenza pandemic; Prophylactic treatment

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; HEALTH CARE PERSONNEL; HUMAN; INFLUENZA; MATHEMATICAL MODEL; MORBIDITY; MORTALITY; PANDEMIC; PROPHYLAXIS; SOCIOECONOMICS;

EID: 34547647307     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2006.0204     Document Type: Article

References (31)

1. Arino, J., Brauer, F., van den Driessche, P., Watmough, J. & Wu, J. 2006 Simple models for containment of a pandemic. J. R. Soc. Interface 3, 453-457. (doi:10.1098/rsif.2006.0112)
2. Balicer, R. D., Huerta, M., Davidovitch, N. & Grotto, I. 2005 Cost-benefit of stockpiling drugs for influenza pandemic. Emerg. Infect. Dis. 11, 1280-1282.
3. Bridges, C. B., Kuehnert, M. J. & Hall, C. B. 2003 Transmission of influenza: implications for control in health care settings. Clin. Infect. Dis. 37, 1094-1101. (doi:10.1086/378292)
4. Cinti, S., Chenoweth, C. & Monto, A. S. 2005 Preparing for pandemic influenza: should hospitals stockpile oseltamivir? Infect. Cont. Hosp. Epidemiol. 26, 852-854. (doi:10.1086/502507)
5. Cox, N. J., Tamblyn, S. E. & Tam, T. 2003 Influenza pandemic planning. Vaccine 21, 1801-1803. (doi:10.1016/S0264-410X(03)00076- 8)
6. Diekmann, O. & Heesterbeek, J. A. P. 2000 Mathematical epidemiology of infectious diseases. Chichester, UK: Wiley.
7. Elder, A. G., O'Donnell, B., McCruden, E. A., Symington, I. S. & Carman, W. F. 1996 Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire. Br. Med. J. 313, 1241-1242.
8. Ferguson, N. M., Mallett, S., Jackson, H., Roberts, N. & Ward, P. 2003 A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals. J. Antimicrob. Chemother. 51, 977-990. (doi:10.1093/jac/dkg136)
9. Ferguson, N. M., Cummings, D. A. T., Cauchemez, S., Fraser, C, Riley, S., Meeyai, A., Iamsirithaworn, S. & Burke, D. S. 2005 Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437, 209-214. (doi:10.1038/nature04017)
10. Ferguson, N. M., Cummings, D. A., Fraser, C., Cajka, J. C., Cooley, P. C. & Burke, D. S. 2006 Strategies for mitigating an influenza pandemic. Nature 442, 448-452. (doi:10.1038/nature04795)
11. Gani, R., Hughes, H., Fleming, D., Griffin, T., Medlock, J. & Leach, S. 2005 Potential impact of antiviral drug use during influenza pandemic. Emerg. Infect. Dis. 9, 1355-1362.
12. Hoft, D. F. & Belshe, R. B. 2004 The genetic archaeology of influenza. New Engl. J. Med. 351, 2550-2551. (doi:10.1056/ NEJMcibr043708)
13. Horcajada, J. P. et al. 2003 A nosocomial outbreak of influenza during a period without influenza epidemic activity. Eur. Respir. J. 21, 303-307. (doi:10.1183/09031936.03.00040503)
14. Jefferson, T., Demicheli, V., Rivetti, D., Jones, M., Di Pietrantonj, C. & Rivetti, A. 2006 Antivirals for influenza in healthy adults: systematic review. Lancet 367, 303-313. (doi:10.1016/S0140-6736(06)67970-1)
15. Lee, V. J., Phua, K. H., Chen, M. I., Chow, A., Ma, S., Goh, K. T. & Leo, Y. S. 2006 Economics of neuraminidase inhibitor stockpiling for pandemic influenza, Singapore. Emerg. Infect. Dis. 12, 95-102.
16. Longini Jr, I. M., Halloran, M. E., Nizam, A. & Yang, Y. 2004 Containing pandemic influenza with antiviral agents. Am. J. Epidemiol. 159, 623-633. (doi:10.1093/aje/kwh092)
17. Longini Jr, I. M., Nizam, A., Xu, S., Ungchusak, K., Hanshaoworakul, W., Cummings, D. A. T. & Halloran, M. E. 2005 Containing pandemic influenza at the source. Science 309, 1083-1087. (doi:10.1126/science.1115717)
18. Low, J. G. H. & Wilder-Smith, A. 2005 Infectious respiratory illnesses and their impact on healthcare workers: a review. Ann. Acad. Med. 34, 105-110.
19. Moscona, A. 2005 Oseltamivir resistance - disabling our influenza defenses. New Engl. J. Med. 353, 2633-2636. (doi:10.1056/ NEJMp058291)
20. McKay, M. D., Conover, W. J. & Beckman, R. J. 1979 A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics 21, 239-245. (doi:10.2307/1268522)
21. Meltzer, M. I., Cox, N. J. & Fukuda, K. 1999 The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg. Infect. Dis. 5, 659-671.
22. Nguyen-Van-Tam, J., Granfield, R., Pearson, J., Fleming, D. & Keating, N. 1999 Do influenza epidemics affect patterns of sickness absence among British hospital staff? Infect. Control Hosp. Epidemiol. 20, 691-694. (doi:10.1086/501568)
23. Nicholson, K. G., Wood, J. M. & Zambon, M. 2003 Influenza. Lancet 362, 1733-1745. (doi:10.1016/S0140-6736(03)14854-4)
24. Rogers, R. R. & Bonhoeffer, S. 2006 Emergence of drug-resistance influenza virus: population dynamical considerations. Science 312, 389-391. (doi:10.1126/science.1122947)
25. Salgado, C. D., Farr, B. M., Hall, K. K. & Hayden, F. G. 2002 Influenza in the acute hospital setting. Lancet Infect. Dis. 2, 145-155. (doi:10.1016/S1473-3099(02)00221-9)
26. Simeonsson, K., Summers-Bean, C. & Connolly, A. 2004 Influenza vaccination of healthcare workers: institutional strategies for improving rates. NC Med. J. 65, 323-329.
27. Taubenberger, J. K. & Morens, D. M. 2006 1918 influenza: the mother of all pandemics. Emerg. Infect. Dis. 12, 15-22.
28. van den Driessche, P. & Watmough, J. 2002 Reproduction numbers and subthreshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 180, 29-48. (doi:10.1016/S0025- 5564(02)00108-6)
29. Weingarten, S., Riedinger, M., Bolton, L. B., Miles, P. & Ault, M. 1989 Barriers to influenza vaccine acceptance. A survey of physicians and nurses. Am. J. Infect. Control. 17, 202-207. (doi:10.1016/0196- 6553(89)90129-6)
30. WHO report on global surveillance of epidemic-prone infectious diseases, 2000, WHO/CDS/CSR/ISR/2000.1.
31. World Health Organization Writing Group 2006 Nonpharmaceutical interventions for pandemic influenza, international measures. Emerg. Infect. Dis. 12, 81-87.